Benmoxin
![]() | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | None |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
7654-03-7 |
| PubChem (CID) | 71671 |
| ChemSpider |
64728 |
| UNII |
XC9FY2SGBG |
| ChEMBL |
CHEMBL1877495 |
| Chemical and physical data | |
| Formula | C15H16N2O |
| Molar mass | 240.30 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class.[1][2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.[1][2]
See also
References
- 1 2 Ganellin, C. R.; Triggle, David J. (1996). Dictionary of Pharmacological Agents, Volumes 1-2. Chapman & Hall. p. 229. ISBN 0-9630096-0-5.
- 1 2 Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.
This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
